Stockreport

Iovance's lifileucel shows sustained benefit in melanoma study [Seeking Alpha]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF Iovance Biotherapeutics (IOVA-1.2%announcesC-144-01Median duration of response has not been reached after almost a median of 19 months. As of April, 23, the overall resp [Read more]